Johnson & Johnson Q4 Profit Decreases

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.
Stifel analyst Rick Wise lowered the firm’s price target on Johnson & Johnson to $155 from $170 and keeps a Hold rating on the shares.
How far would you go to live a longer, healthier life? For tech entrepreneur Bryan Johnson, the answer is “as far as possible ...
The move was intended in part to prevent the release of sexually explicit texts that lawmakers sent Cassidy Hutchinson.
Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...
Shares of robotic surgery pioneer Intuitive Surgical (NASDAQ: ISRG) have been soaring lately. A preliminary look at sales results from the fourth quarter of 2024 suggests its business is on the right ...
JOHNSON CITY, N.Y. (WBNG) -- In this week’s edition of “You Ask, We Answer,” 12 News learned the functions and history of the folded stop signs in the Villages of Johnson City and Endicott.
Follow live updates and coverage on Trump's administration as the president addresses the World Economic Forum and the Senate ...